TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,172 JPY | +0.34% |
|
+3.57% | +2.91% |
| 25/06 | US CDC alerts healthcare providers of increase in dengue cases | RE |
| 25/06 | Takeda's Cancer Drug Gets European Commission Approval | MT |
Presenter SpeechNaomi Kumagai (Analysts)Hi, good afternoon, everyone. Welcome to the conferenc...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas:
- sale of drugs and consumer care products;
- services.
Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).
Sector
Pharmaceuticals
Calendar
31/07/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,158
JPY
Average target price
4,744
JPY
Spread / Average Target
+14.10%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.91% | 4.06TCr | |
| +55.95% | 82TCr | |
| +43.23% | 64TCr | |
| -6.98% | 35TCr | |
| +19.08% | 33TCr | |
| +9.05% | 30TCr | |
| +17.18% | 24TCr | |
| +2.74% | 23TCr | |
| +13.29% | 22TCr | |
| +8.91% | 17TCr |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Transcript : Takeda Pharmaceutical Company Limited Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 02
